Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Corey

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 3, 2014
Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patientsYvonne C W Yau, Felix Ratjen, Elizabeth Tullis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 12, 2010
TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosisChristoph J Blohmke, Julie Park, Aaron F Hirschfeld, et al.
American Journal of Respiratory Cell and Molecular Biology|April 12, 2003
Alpha 1-antitrypsin deficiency alleles in cystic fibrosis lung diseaseDespina D Frangolias, Jian Ruan, Pearce J Wilcox, et al.
Human Genetics|September 30, 2005
The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitisMichele D Bishop, Steven D Freedman, Julian Zielenski, et al.
The New England Journal of Medicine|October 7, 2005
Genetic modifiers of lung disease in cystic fibrosisMitchell L Drumm, Michael W Konstan, Mark D Schluchter, et al.
American Journal of Respiratory and Critical Care Medicine|March 20, 2019
Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic FibrosisAllison F McCague, Karen S Raraigh, Matthew J Pellicore, et al.
Pediatric Pulmonology|April 5, 2011
A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis genetic modifier studiesChelsea Taylor, Clayton W Commander, Joseph M Collaco, et al.
Nature Genetics|August 27, 2013
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator genePatrick R Sosnay, Karen R Siklosi, Fredrick Van Goor, et al.
Human Genetics|August 8, 2009
Modifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping resultsRuslan Dorfman, Weili Li, Lei Sun, et al.
Nature Genetics|April 3, 2012
Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosisLei Sun, Johanna M Rommens, Harriet Corvol, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 3, 2014
Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patientsYvonne C W Yau, Felix Ratjen, Elizabeth Tullis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 12, 2010
TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosisChristoph J Blohmke, Julie Park, Aaron F Hirschfeld, et al.
American Journal of Respiratory Cell and Molecular Biology|April 12, 2003
Alpha 1-antitrypsin deficiency alleles in cystic fibrosis lung diseaseDespina D Frangolias, Jian Ruan, Pearce J Wilcox, et al.
Human Genetics|September 30, 2005
The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitisMichele D Bishop, Steven D Freedman, Julian Zielenski, et al.
The New England Journal of Medicine|October 7, 2005
Genetic modifiers of lung disease in cystic fibrosisMitchell L Drumm, Michael W Konstan, Mark D Schluchter, et al.
American Journal of Respiratory and Critical Care Medicine|March 20, 2019
Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic FibrosisAllison F McCague, Karen S Raraigh, Matthew J Pellicore, et al.
Pediatric Pulmonology|April 5, 2011
A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis genetic modifier studiesChelsea Taylor, Clayton W Commander, Joseph M Collaco, et al.
Nature Genetics|August 27, 2013
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator genePatrick R Sosnay, Karen R Siklosi, Fredrick Van Goor, et al.
Human Genetics|August 8, 2009
Modifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping resultsRuslan Dorfman, Weili Li, Lei Sun, et al.
Nature Genetics|April 3, 2012
Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosisLei Sun, Johanna M Rommens, Harriet Corvol, et al.
Pageof 8